TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17239698

Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/20 mg + fenofibrate 160 mg (EZE/SIMVA + FENO)
Number of subjects: 611
Study: 15692328

Group type: EXPERIMENTAL
Intervention: 6% CHO solution
Number of subjects: 20
Study: 12670094

Group type: EXPERIMENTAL
Intervention: Ultrasonic furcation tip
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ultrasonic conventional tip and hand scalers
Number of subjects: 15
Study: 9578503

Group type: EXPERIMENTAL
Intervention: Infants with a father who smoked (Group B)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Infants with both parents being smokers (Group C)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Infants with non-smoking parents (Group A)
Number of subjects: 54
Study: 1961665

Group type: EXPERIMENTAL
Intervention: Caffeine 5.0 mg/kg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Caffeine 2.5 mg/kg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (200 mg. methylcellulose)
Number of subjects: 16
Study: 6794592

Group type: EXPERIMENTAL
Intervention: Oral disodium cromoglycate (DSCG)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30641025

Group type: EXPERIMENTAL
Intervention: Mentored group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Non-mentored group
Number of subjects: 16
Study: 31141730

Group type: EXPERIMENTAL
Intervention: Single treatment of MAL DL‐PDT
Number of subjects: 31

Group type: COMPARATOR
Intervention: Two treatments of MAL DL‐PDT (1 week apart)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Two treatments of MAL DL‐PDT
Number of subjects: 31
Study: 28429904

Group type: EXPERIMENTAL
Intervention: 10 mg/d of lutein for 36 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Identical placebo for 36 weeks
Number of subjects: 31
Study: 26057285

Group type: EXPERIMENTAL
Intervention: Real-time control system using EMG signals and historical information
Number of subjects: 7

Group type: COMPARATOR
Intervention: Real-time control system using mechanical sensor data only
Number of subjects: 7
Study: 23561480

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide 2% soaked gauze for 5 minutes followed by normal saline irrigation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional method of debridement and skin grafting
Number of subjects: 49
Study: 21671489

Group type: EXPERIMENTAL
Intervention: rTMS (10 Hz, 90% motor threshold) combined with citalopram (20 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham procedure combined with citalopram (20 mg/d)
Number of subjects: 60
Study: 19489241

Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine with 0.5 microg/ml sufentanil (latent group)
Number of subjects: 360

Group type: COMPARATOR
Intervention: 0.15% ropivacaine with 0.5 microg/ml sufentanil (active group)
Number of subjects: 360
Study: 16221926

Group type: EXPERIMENTAL
Intervention: Methylphenidate (NE agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cabergoline (DA agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tacrine (ACh agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prazosin (NE antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol (DA antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biperiden (ACh antagonist)
Number of subjects: 0
Study: 15330271

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saturated fat enriched diet (SFA)
Number of subjects: 41
Study: 11122852

Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 0
Study: 1523161

Group type: EXPERIMENTAL
Intervention: Des-glycinamide-[Arg8]vasopressin (DGAVP, 2 mg intranasal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxytocin (OXT, 20 IU intranasal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6208877

Group type: EXPERIMENTAL
Intervention: Graded elastic compression stockings
Number of subjects: 80
Study: 30460999

Group type: EXPERIMENTAL
Intervention: Screening arm (FOBT)
Number of subjects: 321311

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 321311
Study: 28328726

Group type: EXPERIMENTAL
Intervention: Cleadew cleaning and disinfecting system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Habitual multipurpose disinfecting system
Number of subjects: 0
Study: 27008910

Group type: EXPERIMENTAL
Intervention: Intensive training with an instrumented exercise workstation and functional electrical stimulation for 1 hour per day, 5 days per week for 8 weeks.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care plus three 15-minute sessions per week of one-to-one hand therapy without functional electrical stimulation.
Number of subjects: 70
Study: 24613825

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with mild AMD (n=30)
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with moderate AMD (n=346)
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with severe AMD (n=462)
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with noncentral geographic atrophy (n=70)
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with advanced AMD (n=324)
Number of subjects: 793
Study: 23242726

Group type: EXPERIMENTAL
Intervention: Tramadol (1 mg/kg)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Paracetamol (15 mg/kg)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 20184576

Group type: EXPERIMENTAL
Intervention: Prelox (complex plant extract)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 18378563

Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg for 7 days
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg for 7 days
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Fluconazole coadministration
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: CYP2C9(*)3 alleles presence
Number of subjects: 189
Study: 15764773

Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 200

Group type: COMPARATOR
Intervention: CABG/CPB
Number of subjects: 200
Study: 12572696

Group type: EXPERIMENTAL
Intervention: Screening modalities of demonstrated effectiveness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population-based screening programmes
Number of subjects: 0
Study: 10587285

Group type: EXPERIMENTAL
Intervention: Bioglycin
Number of subjects: 2
Study: 8934867

Group type: EXPERIMENTAL
Intervention: Stimulus control (received a letter by mail plus a complimentary 'EXERCISE' key chain)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (received a letter by mail)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (received no intervention)
Number of subjects: 200
Study: 1940933

Group type: EXPERIMENTAL
Intervention: Cemented fixation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Cementless fixation
Number of subjects: 43
Study: 6720317

Group type: EXPERIMENTAL
Intervention: 0.125 mg terbutaline intramuscularly
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.25 mg terbutaline intramuscularly
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.5 mg terbutaline intramuscularly
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 2.5 mg terbutaline inhalation
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30056409

Group type: EXPERIMENTAL
Intervention: Bodyblade (experimental group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General physiotherapy (control group)
Number of subjects: 30
Study: 29608445

Group type: EXPERIMENTAL
Intervention: Access to HIV and syphilis testing at 300 pathology centers without requiring consultations
Number of subjects: 419

Group type: COMPARATOR
Intervention: Consultation at every test (control group)
Number of subjects: 419
Study: 26854123

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Number of subjects: 331

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy (continuation phase)
Number of subjects: 331

Group type: COMPARATOR
Intervention: MDI to pump therapy (continuation phase)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Insulin pump therapy and MDI
Number of subjects: 331
Study: 24424357

Group type: EXPERIMENTAL
Intervention: G‐CSF (Filgrastim, Amgen, 300 μg/1.0 mL)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 141
Study: 23506652

Group type: EXPERIMENTAL
Intervention: PIFU-PL (plain language Patient Instructions for Use)
Number of subjects: 50
Study: 21683527

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 114
Study: 18178293

Group type: EXPERIMENTAL
Intervention: Thymectomized children after second vaccination
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Thymectomized children after third vaccination
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Thymectomized children
Number of subjects: 17

Group type: COMPARATOR
Intervention: Healthy age-matched controls, n=30
Number of subjects: 17
Study: 16455634

Group type: EXPERIMENTAL
Intervention: [188Re]anti‐CD66
Number of subjects: 114

Group type: COMPARATOR
Intervention: [90Y]anti‐CD66
Number of subjects: 114
Study: 14663604

Group type: EXPERIMENTAL
Intervention: Fibrinogen/LDL-apheresis
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard therapy (prednisolone, hydroxyethyl starch, pentoxifylin)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Fibrinogen/LDL-apheresis in patients with plasma fibrinogen >295 mg/dl
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard therapy in patients with plasma fibrinogen >295 mg/dl
Number of subjects: 201
Study: 10826426

Group type: EXPERIMENTAL
Intervention: Loop ileostomy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Loop colostomy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Stoma care problems
Number of subjects: 76
Study: 8880846

Group type: EXPERIMENTAL
Intervention: Not applicable, as this study is a database creation and not a clinical trial with interventions.
Number of subjects: 8000
Study: 1497047

Group type: EXPERIMENTAL
Intervention: Maternal hyperoxygenation (oxygen-treated group, n = 17)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Untreated group (n = 19)
Number of subjects: 36
Study: 6351364

Group type: EXPERIMENTAL
Intervention: TCu 220C
Number of subjects: 2340

Group type: EXPERIMENTAL
Intervention: Lippes Loop D
Number of subjects: 2340

Group type: EXPERIMENTAL
Intervention: Copper 7
Number of subjects: 2340

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 2340
Study: 31932569

Group type: EXPERIMENTAL
Intervention: Spouse-participated health coaching for 12 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Health coaching only for workers
Number of subjects: 26
Study: 29385178

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate (HC) meal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-Protein (HP) meal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-Fat (HF) meal
Number of subjects: 18
Study: 27090097

Group type: COMPARATOR
Intervention: Single session Brief Intervention/Referral to Treatment (BI/RT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Multi-session Brief Intervention/Referral to Treatment (BI/RT+)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Both interventions (BI/RT and BI/RT+)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Economic evaluation
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Process evaluation
Number of subjects: 600
Study: 25242204

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (2×500 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22897461

Group type: EXPERIMENTAL
Intervention: Rosuvastatin monotherapy 40 mg/day (R group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day combined with fenofibrate 200 mg/day (RF group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg/day combined with ω-3 fatty acids 2 g/day (Rω group)
Number of subjects: 71
Study: 20190066

Group type: EXPERIMENTAL
Intervention: Population-based informatics system (PRECARES)
Number of subjects: 689

Group type: COMPARATOR
Intervention: Control group (comparable third section)
Number of subjects: 689
Study: 17033631

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) 40,000 IU weekly intravenous infusion for 12 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO)
Number of subjects: 39
Study: 15875240

Group type: EXPERIMENTAL
Intervention: Suprapubic arc (SPARC) sling
Number of subjects: 62

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 62
Study: 11953541

Group type: EXPERIMENTAL
Intervention: Home visits by an occupational therapist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no home visits)
Number of subjects: 60
Study: 9607691

Group type: EXPERIMENTAL
Intervention: 30 microg ethinyloestradiol + 150 microg desogestrel for 3 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: 35 microg ethinyloestradiol + 2 mg cyproterone acetate for 3 months
Number of subjects: 33
Study: 8550255

Group type: EXPERIMENTAL
Intervention: Pre-exercise glucose polymer (G) and placebo during exercise (G/P)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Glucose polymer pre-exercise and during exercise (G/G)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo pre-exercise and during exercise (P/P)
Number of subjects: 5
Study: 1965645

Group type: EXPERIMENTAL
Intervention: 50 mg cicletanine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 mg cicletanine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no cicletanine)
Number of subjects: 0
Study: 82784

Group type: EXPERIMENTAL
Intervention: myo-inositol, 500 mg twice a day
Number of subjects: 7
Study: 30745383

Group type: EXPERIMENTAL
Intervention: Oxfendazole (0.5, 1, 3, 7.5, 15, 30, or 60 mg/kg body weight)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 28143430

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen (10 mg/kg)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Acetaminophen (10 mg/kg)
Number of subjects: 103
Study: 25818379

Group type: EXPERIMENTAL
Intervention: Indication-based off-label medication order scenarios with lower relative expert power
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Indication-based off-label medication order scenarios with less appropriate prescriptions
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Indication-based off-label medication order scenarios
Number of subjects: 243
Study: 23892761

Group type: EXPERIMENTAL
Intervention: Probe-based confocal laser endomicroscopy (pCLE)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Off-site probe-based confocal laser endomicroscopy (pCLE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autofluorescence Imaging (AFI)
Number of subjects: 20
Study: 21926932

Group type: EXPERIMENTAL
Intervention: Tualang honey (20 g/d)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin therapy (Femoston 1/5)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Tualang honey
Number of subjects: 102
Study: 19468011

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Number of subjects: 89

Group type: COMPARATOR
Intervention: Bivalirudin
Number of subjects: 89
Study: 17018340

Group type: EXPERIMENTAL
Intervention: Cardiac contractility modulation signals (n = 25, treatment group)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n = 24, devices programmed to remain off)
Number of subjects: 49
Study: 12629429

Group type: EXPERIMENTAL
Intervention: Worksite physical activity program
Number of subjects: 26
Study: 10892932

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-frequency electrocauter (HF)
Number of subjects: 24
Study: 9370848

Group type: EXPERIMENTAL
Intervention: Toothguard
Number of subjects: 80

Group type: COMPARATOR
Intervention: No Toothguard (Control)
Number of subjects: 80
Study: 1286044

Group type: EXPERIMENTAL
Intervention: Cisplatin (chemotherapy)
Number of subjects: 124
Study: 3702214

Group type: EXPERIMENTAL
Intervention: High protein diet (1.6 g/kg body wt)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low protein diet (0.8 g/kg body wt)
Number of subjects: 9
Study: 31589971

Group type: EXPERIMENTAL
Intervention: Post-diagnosis vitamin D levels
Number of subjects: 240

Group type: COMPARATOR
Intervention: Pre-diagnosis vitamin D levels
Number of subjects: 240
Study: 30076447

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) delivered with high‐frequency high‐intensity ultrasound
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 27622453

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg every 12 h for 48 h after an initial preoperative dose of parecoxib 40 mg
Number of subjects: 240

Group type: COMPARATOR
Intervention: Saline every 12 h for 48 h after an initial preoperative dose of saline
Number of subjects: 240
Study: 24905068

Group type: EXPERIMENTAL
Intervention: Interval walking (IW)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (IW)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Continuous walking (CW)
Number of subjects: 10
Study: 22428845

Group type: EXPERIMENTAL
Intervention: Interferon beta (IFNβ) treatment
Number of subjects: 172
Study: 20660592

Group type: EXPERIMENTAL
Intervention: Self-medication for STI symptoms
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Work in brothels
Number of subjects: 1601

Group type: COMPARATOR
Intervention: Awareness of STI services available for FSW
Number of subjects: 1601
Study: 18713889

Group type: EXPERIMENTAL
Intervention: Acupressure at Extra-1 point
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 52
Study: 14984518

Group type: EXPERIMENTAL
Intervention: s(+)-ketamine and morphine
Number of subjects: 28

Group type: COMPARATOR
Intervention: saline and morphine
Number of subjects: 28
Study: 11384629

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/d and MPA 2.5 mg/d
Number of subjects: 2673

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/d
Number of subjects: 2673

Group type: EXPERIMENTAL
Intervention: All active treatment groups
Number of subjects: 2673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2673
Study: 8996159

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) administered as a 3-hour infusion at dosages of 100 to 250 mg/m2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Carboplatin (C) administered over 30 minutes at dosages of 300 to 400 mg/m2
Number of subjects: 55

Group type: COMPARATOR
Intervention: Paclitaxel (P) and Carboplatin (C) administered in different sequences
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) at doses < 175 mg/m2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) at doses >= 175 mg/m2
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) with P‐T > or = 0.1 mumol/L for < 15 hours
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) with P‐T > or = 0.1 mumol/L for >= 15 hours
Number of subjects: 55
Study: 8485612

Group type: EXPERIMENTAL
Intervention: Cilag Estradiol‐TTS (matrix system)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Ciba‐Geigy Estradiol‐TTS (reservoir system)
Number of subjects: 530
Study: 2441152

Group type: EXPERIMENTAL
Intervention: Diuretic (frusemide)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Venodilator (isosorbide dinitrate)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Arteriolar dilator (hydralazine)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Positive inotropic stimulation (prenalterol)
Number of subjects: 48
Study: 29948021

Group type: EXPERIMENTAL
Intervention: Sirolimus with Metformin (Arm A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sirolimus (Arm B)
Number of subjects: 24
Study: 26996929

Group type: EXPERIMENTAL
Intervention: Pediatric heart transplantation (PHTx)
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Stroke after PHTx
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Congenital heart disease
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Previous stroke
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: History of aborted sudden death
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Ventricular assist device
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Post-operative dialysis
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Infection requiring antibiotics before discharge
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Pacemaker implantation
Number of subjects: 9837

Group type: EXPERIMENTAL
Intervention: Drug-treated hypertension
Number of subjects: 9837
Study: 24819236

Group type: EXPERIMENTAL
Intervention: Adherence to vademecum rules (Group two)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No changes in lifestyle (Group one)
Number of subjects: 100
Study: 22051768

Group type: EXPERIMENTAL
Intervention: Chest Pain Unit (CPU)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Emergency Department (ED)
Number of subjects: 1012
Study: 20833992

Group type: EXPERIMENTAL
Intervention: Pistachio nuts (53g, 240 cal)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Refined carbohydrate snack (salted pretzels, 56g, 220 cal)
Number of subjects: 59
Study: 19021487

Group type: EXPERIMENTAL
Intervention: Outlook intervention (discussions of end-of-life preparation and completion)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Attention control (listening to a nonguided relaxation CD)
Number of subjects: 82

Group type: COMPARATOR
Intervention: True control (no intervention)
Number of subjects: 82